Virology Testing Market

Virology Testing Market - Size,
Opportunity Analysis, 2018 – 2026
Outlook,
and
Virology testing consist of diagnostic methods that help in early detection of the disease such as
hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease.
Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the
given sample in order to confirm the presence of particular viral infection. There are more than
100 viral diseases identified.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/2037
In order to confirm viral infections, virology testing inculcates various methods. Culture medium
based method in which virus is confirmed by colony formation over culture has been
traditionally used since long time. Although this method is widely acceptable and easy to
perform, it is often time consuming, as it takes few days to weeks to confirm presence of
particular virus. It is a serious limitation especially in viral pandemics where loss of time could
result in more widespread infection and delay in management of the viral infection.
New advanced molecular based virology testing methods has been evolved in recent past such
as immunoassay, nucleic acid based amplification testing methods (PCR based methods), mass
spectrometry based detection methods and next generation genome sequencing methods, which
are accurate, quick, and provides result for diversified viral infections.
Virology Testing Market- Market Dynamics
Virology testing market is projected to witness significant growth during forecast period with
rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola,
Influenza based viral infections, severe acute respiratory syndrome from coronavirus,
hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential
to start treatment course.
According to the World Health Organization (WHO), January 2018 factsheet, all types of
influenza in combination causes annual epidemics about 3 to 5 million cases with severe stage
of illness, which results in the 290 000 to 650 000 deaths worldwide annually. Although rapid
diagnostic tests are majorly used, PCR based techniques are being adopted for detection of
influenza.
According Report on Global Sexually Transmitted Infection Surveillance published in 2015 by
WHO, in 2012, an estimated 357 million new infections, which is equivalent to roughly 1
million patients per day were reported for the four curable sexually transmitted disease such as
chlamydia, gonorrhea, syphilis, and trichomoniasis.
Furthermore, advances in anti-viral therapy in terms of detection techniques, medication, and
vaccines are expected to drive the virology testing market growth. Worldwide efforts are going
on to find novel vaccines and novel medication for treating viral resistant diseases. For
instance, Pritelivir is investigational drug for herpes simplex virus (HSV) by AiCuris has proven
to be very effective as compared to the current standard antiviral treatments for genital herpes
in Phase II trials. Extensive research has been conducted worldwide for treatment of high
epidemic viral disease such as Ebola, Dengue, and Malaria.
New technologies for detecting and curing viral disease could help in market expansion. For
instance, the nanoscale viral trap molecule technology, which is under research at present can
be applicable in diagnosing a viral disease. An innovative tunable device selectively traps
viruses detecting them with 100 times better sensitivity than the current available techniques.
Double-stranded RNA Activated Caspase Oligomerizer (DRACO) is another nanoparticle based
drug in research to treat viral disease.
Advancement in diagnostic technologies from culture based methods to nucleic acid and
molecular diagnosis techniques is leading to new product launches by key players, which is
expected to drive growth of virology testing market. For instance, Roche in 2017, launched
cobas HPV Assay to be performed on the cobas 6800/8800 Systems. Cobas HPV assay aids in
identifying women at risk of cervical cancer, performed on cobas 6800/8800 Systems which is
fully automated system with capacity to deliver large diagnostic services.
Report includes chapters which deeply display the following deliverable about industry :
• Virology Testing Market Research Objective and Assumption
• Virology Testing Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Virology Testing Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Virology Testing Market, By Regions
• Virology Testing Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Virology Testing Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Virology Testing Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Virology Testing Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Ask For Discount Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/2037
Virology Testing Market - Regional Insights
On the basis of Geography, virology testing market is segmented into North America, Latin
America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to dominate
the virology testing market over the forecast period. According to the Centers for Disease
Control and Prevention (CDC), around 5,251 deaths were reported due to influenza infection in
2015.
According to the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8
million people visit to physician for treatment of infectious and parasitic diseases in U.S.
Moreover, according to a study from the Society for Risk Analysis, 2016, GDP loss of a viral
pandemic outbreak in the U.S. was recorded between US$ 34.4 billion and US$ 45.3 billion in
2015.
Furthermore, robust healthcare infrastructure and highest healthcare spending in world makes
the U.S. most lucrative market. However, Asia Pacific is expected to witness high CAGR due to
outbreak of viral influenza and largest patient pool infected with HIV.
Virology Testing Market - Competitive Landscape
Some of the key players operating in the virology testing market include F. Hoffmann-La Roche
AG., Bio-Rad Laboratories Inc. , Hologic Inc., Abbot Healthcare, Fujirebio Diagnostics Inc.,
Thermo Fisher Scientific Inc., Cepheid, bioMerieux SA, Qiagen, Diasorin, Scienion AG, Siemens
AG Grifols, Eiken Chemical Co Ltd., Sequenom, and Diamedix Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease.

Download Report